Press release
Congestive Heart Failure Treatment Devices Market: Medical Management, Recent Developments, and Future Challenges
Medical experts have recognized sedentary lifestyles and unhealthy food choices, which lead to conditions such as coronary artery diseases, cardiomyopathy, as critical reasons for heart failure. While the first steps of treatment range from tight control over diet and medications to lifestyle, in the event of the progression of the condition, more advanced treatment options need to be administered.Browse Full Report : http://www.transparencymarketresearch.com/congestive-heart-failure-treatment-devices-market.html
In a new report by Transparency Market Research, the progression of the global congestive heart failure devices market is presented for a forecast period from 2012 to 2018. According to the report’s findings, the global congestive failure treatment devices market will display double-digit growth rate in the coming years. A complete analysis of vital market indicators, technological innovations, and the competitive structure of this market is presented in the report, titled “Congestive Heart Failure Treatment Devices Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 – 2018.” The report studies this market across the regional segments of North America, Europe, Asia Pacific, and Rest of the World for the aforementioned forecast period.
The top players that are at the forefront of the global market for congestive heart failure treatment devices are Berlin Heart Inc., Jarvik Heart, Teleflex Inc., MicroMed Cardiovascular Inc., AbioMed, Biotronik, Boston Scientific, Medtronic Inc., St. Jude Medical Inc., World Heart Corporation, Thoratec, and others.
Congestive heart failure (CHF) happens when the heart muscles do not pump blood as they should to meet the metabolic needs of tissue and body organs. The increasing incidence of heart failures worldwide, an increasing geriatric population pool, greater awareness about CHF, and changing lifestyles are driving the growth of the congestive heart failure treatment devices market, says the report.
The U.S. and European markets hold immense growth potential for congestive heart failure treatment devices on account of the increasing incidence of congestive heart failures in these regions. This is evident from the increasing valuation of the American market for congestive heart failure treatment devices over the past few years.
Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=396
In absolute numbers, the American market for congestive heart failure treatment devices stood at US$1.6 bn in 2010 and will be valued at US$3.2 bn by the end of 2016. Likewise, the Europe market is expected to reach a valuation of US$1.5 bn by the end of 2016. The emerging markets of Asia Pacific and Latin America will display significant growth due to reforms aimed at modernizing healthcare practices, the changing demographics, increasing income levels, and availability of newer treatments for congestive heart failure.
Product-wise, the major devices for congestive heart failure treatment are ventricular assist devices, counterpulsation devices, and implantable cardioverter defibrillators (ICDs).
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email:Â sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Congestive Heart Failure Treatment Devices Market: Medical Management, Recent Developments, and Future Challenges here
News-ID: 340147 • Views: …
More Releases from Transparency Market Research
Global Ophthalmic Sutures Market to Reach USD 1.3 Billion by 2034, Driven by Ris …
The global Ophthalmic Sutures Market is experiencing significant momentum as demand surges for improved ophthalmic surgical outcomes amid increasing incidences of ocular disorders worldwide. According to the latest industry assessment, the market, valued at US$ 629.0 million in 2023, is projected to expand at a CAGR of 6.5% between 2024 and 2034, ultimately reaching US$ 1.3 billion by 2034.
This comprehensive press release provides an in-depth examination of market size, trends,…
Global Ophthalmology PACS Market to Reach USD 359.8 Mn by 2034, Driven by Rising …
The global Ophthalmology PACS (Picture Archiving and Communication System) Market is poised for strong expansion over the next decade as the industry continues transitioning toward digital, AI-enabled ophthalmic imaging management solutions. According to recent market assessments, the global Ophthalmology PACS market valued at US$ 167.8 Mn in 2023 is projected to grow at a CAGR of 7.3% from 2024 to 2034, ultimately reaching US$ 359.8 Mn by the end of…
Global Ophthalmology Surgical Devices Market Set to Reach USD 12.1 Billion by 20 …
The global Ophthalmology Surgical Devices Market is poised for steady expansion, driven by rising demand for advanced surgical systems, increasing prevalence of cataracts and glaucoma, and accelerating adoption of minimally invasive techniques. The market was valued at US$ 8.1 billion in 2022 and is projected to reach US$ 12.1 billion by 2031, expanding at a CAGR of 4.7% from 2023 to 2031.
Unlock crucial data and key findings from our Report…
Global Opioid Use Disorders Market to Reach US$ 8.8 Billion by 2034, Driven by R …
The global Opioid Use Disorders (OUD) Market is set for strong expansion over the next decade, rising from US$ 3.2 billion in 2023 to an estimated US$ 8.8 billion by 2034, according to the latest industry assessment. The market is projected to grow at a CAGR of 9.9% from 2024 to 2034, supported by increasing government funding, rising public awareness, and the escalating prevalence of opioid addiction across all major…
More Releases for Heart
Heart Healthy Foods and Supplements vs Heart Conditions
Heart conditions remain a major health concern worldwide, but the good news is that specific heart healthy foods and supplements can significantly improve cardiovascular health.
Scientific research has demonstrated that certain foods, nutrients and supplements support heart function, reduce inflammation, and lower the risk of heart disease.
Top Heart Healthy Foods
Fatty Fish - Salmon, mackerel, and sardines are rich in omega-3 fatty acids, which help lower blood pressure and reduce inflammation. A…
Centrifugal Heart Pumps Market | Abbott Laboratories, Abiomed, Berlin Heart, Car …
The global centrifugal heart pumps market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the centrifugal heart pumps market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr
When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue…
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH…
HEART PUMP DEVICES Market 2020 | SWOT Analysis By Top Players Abbott Laboratorie …
A detailed study on HEART PUMP DEVICES Market formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in…
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot
Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after…
